4 Recruiting Systemic Sclerosis Phase 3 Clinical Trials

Active phase 3 studies for systemic sclerosis enrolling across the USA. Verify eligibility and contact site coordinators.

All Systemic Sclerosis studies

Phase 3 Studies for Systemic Sclerosis

🔵 Active, Not Recruiting Phase3

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

📍 Research Site — Scottsdale, Arizona

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase3

A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

📍 Local Institution - 0035 — Scottsdale, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

📍 Yale University — New Haven, Connecticut

View Study & Checklist ➔

🟢 Recruiting Phase3

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

📍 University of Alabama at Birmingham — Birmingham, Alabama

View Study & Checklist ➔